Inhibikase Therapeutics Inc (IKT) financials · $215.2M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Inhibikase Therapeutics Inc (IKT) $215.2M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | N/A | N/A |
| Operating Income | -$52.0M | -$28.6M |
| Net Income | -$48.3M | -$27.5M |
| EPS (Diluted) | -$0.49 | -$1.16 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $181.2M | $98.6M |
| Current Assets | $180.1M | $98.5M |
| Cash & Equivalents | $178.8M | $56.5M |
| PP&E | N/A | $47.1K |
| Total Liabilities | $8.30M | $3.73M |
| Current Liabilities | $8.30M | $3.73M |
| Shareholders' Equity | $172.9M | $94.9M |
| Retained Earnings | -$142.7M | -$94.4M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$27.8M | -$19.1M |
| CapEx | $13.4K | N/A |
| Investing Cash Flow | $2.05M | -$37.0M |
| Financing Cash Flow | $108.5M | $103.5M |
| Free Cash Flow | -$27.8M | -$19.1M |
FAQ
What is IKT P/E and revenue?
Inhibikase Therapeutics Inc (IKT) $215.2M cap.
What is IKT revenue?
IKT income-statement cache has no revenue figure yet.
Is IKT profitable?
Inhibikase Therapeutics Inc last cached net income is -$48.3M (FY2025).
What are IKT total assets?
Inhibikase Therapeutics Inc last cached total assets are $181.2M (FY2025).
What is IKT free cash flow?
Inhibikase Therapeutics Inc last cached free cash flow is -$27.8M (FY2025).
Not investment advice. Cached statements, not a live tape.